Ekso Bionics: A Pivotal Period Ahead as Key Catalysts Approach

Ekso Bionics Holdings is entering what could be a transformative first half of 2026. The company stands at a critical juncture, needing to demonstrate that its technological leadership in the exoskeleton space can be converted into tangible operational and financial growth. A series of imminent financial and product milestones will be central to this effort.

Investors are marking several key dates on their calendars. The financial community will get its next comprehensive look at the company’s performance after the U.S. market closes on March 3, 2026, when Ekso Bionics reports its fourth-quarter and full-year 2025 results.

Simultaneously, the firm’s regulatory and commercial pipelines are set Read more...